ExitWednesday, October 7, 2026
Apposite Capital exits CrestOptics to Evident
The Rome-based maker of optical imaging systems for confocal and super-resolution microscopy is being sold to Evident, marking Apposite Capital's first exit from Healthcare III.
CrestOptics was founded in Rome in 2011 and develops and manufactures optical imaging systems used in spinning disk confocal and super-resolution microscopy. No financial terms of the sale were disclosed.
Deal facts
- Target
- CrestOptics
- Business
- Rome-based developer and manufacturer of optical imaging systems for spinning disk confocal and super-resolution microscopy.
- Buyer
- Evident
- Seller
- Apposite Capital
- Deal type
- Exit
- Headquarters
- Rome, Italy
- Status
- Completed
- Announced
- Wednesday, October 7, 2026
Sources
- PEI Private EquityOct 7, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.